抗肾小球基底膜病合并膜性肾病12例病例系列
该病例系列描述了2001至2019年间单中心收治的12例抗GBM病合并膜性肾病患者,均表现为需透析的严重急性肾损伤,病理以新月体性和坏死性肾小球肾炎伴GBM线性IgG沉积及上皮下电子致密物为特征,全部进展至肾替代治疗,仅2例 later 恢复肾功能。
要点
- 抗GBM病合并膜性肾病罕见,多表现为严重急性肾损伤需透析。
- 病理为新月体性坏死性肾炎伴GBM线性IgG及上皮下电子致密物。
- 所有患者进展至肾替代治疗,仅2例 later 恢复肾功能。
核心结论
- 抗GBM病合并膜性肾病表现为快速进展性肾小球肾炎且肾脏预后差,提示早期诊断可能有益并需探索更有效治疗方案。
研究设计与样本
- 病例系列,纳入2001至2019年单中心收治的12例抗GBM病合并膜性肾病患者,描述临床特征及长期随访。
主要发现
- 患者年龄20至81岁,全部在就诊时或不久后出现需透析的严重急性肾损伤。
- 仅1例就诊时有肺部表现。
- 主要病理为新月体性和坏死性肾小球肾炎伴GBM线性IgG沉积及上皮下电子致密物。
- 11例检测抗GBM抗体者均有显著滴度,5例活检检测PLA2R者仅1例阳性。
- 全部12例进展至需肾替代治疗,其中2例 later 恢复肾功能;无抗GBM病复发。
临床怎么用
- 对表现为快速进展性肾小球肾炎且需透析的患者,应考虑抗GBM病合并膜性肾病的可能,早期识别或有助于管理。
局限性
- 活检和血清PLA2R检测不完整。
- 样本量有限。
- 缺乏统一治疗方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Anti-glomerular basement membrane (GBM) disease is a rapidly progressive glomerulonephritis which, in some instances, occurs concurrently with other diseases such as antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Rarely, it also occurs with membranous nephropathy (MN). We report a series of such patients, characterizing their long-term follow up. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: Twelve patients referred to 1 medical center between 2001 and 2019 with anti-GBM disease and MN whose clinical characteristics and course were described. RESULTS: Patients' ages ranged from 20 to 81 years old, and all presented with severe acute kidney injury requiring dialysis on presentation or shortly thereafter. Only 1 patient had pulmonary findings on presentation. The predominant pathology was crescentic and necrotizing glomerulonephritis with linear staining for immunoglobulin G along the GBM associated with epimembranous electron-dense immune-type deposits. All 11 patients who were tested had significant titers of anti-GBM antibodies, but only 1 of the 5 tested for phospholipase A2 receptor (PLA2R) on biopsy was positive. Eight patients received therapy with cyclophosphamide, prednisone, and plasmapheresis; 2 patients with prednisone and plasmapheresis; and 2 with rituximab-based regimens. Progression to a requirement for kidney replacement therapy occurred in all 12 patients, but 2 patients later recovered kidney function. Recurrence of anti-GBM disease did not occur for any of the patients studied. LIMITATIONS: Incomplete testing for PLA2R in biopsy and serum, limited sample size, and lack of uniform treatment regimen. CONCLUSIONS: In this case series, the presentation of concurrent anti-GBM disease and MN was characterized by rapidly progressive glomerulonephritis and poor kidney outcomes. These findings suggest possible value from earlier diagnosis and the need for identification of more effective treatment regimens.
引用
- Ahmad SB, Santoriello D, Canetta P, et al. Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series. Am J Kidney Dis. 2021. PMID: 33421452. doi:10.1053/j.ajkd.2020.11.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。